Trade TWST anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Twist Bioscience Corporation (TWST) is trading at US$143.70, down 6.14% today as of Aug 28, 13:48 EDT. The company has a market capitalisation of US$9.13B. Over the past 52 weeks, TWST has traded between US$23.30 and US$155.44. On Syfe you can trade TWST with $0 commission and add it to your watchlist.
| Previous close | US$153.10 |
|---|---|
| Market cap | US$9.13B |
| 52-week range | US$23.30 – US$155.44 |
| Volume | 1.25M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Twist Bioscience Corporation
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
Year: 2018
Twist Bioscience Corporation (TWST) stock is trading at US$143.70, -6.14% from the previous close of US$153.10.
The market cap for Twist Bioscience Corporation (TWST) stock is approximately US$9.13B.
The 52-week high for Twist Bioscience Corporation (TWST) stock is US$155.44.
The 52-week low for Twist Bioscience Corporation (TWST) stock is US$23.30.
Twist Bioscience Corporation (TWST) does not currently pay a dividend.
Stay on top of TWST
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
